Exploiting the Body's Immune System to Treat a Broad Range of Diseases

Read more

ARMO in the News

3/29/2017

ARMO BioSciences Announces First Patient Dosed in Pivotal Phase 3 Trial of Immunotherapy AM0010 for Advanced Pancreatic Cancer  Read more